AngioDynamics ANGO

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.31 (-3.29%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of AngioDynamics (ANGO)
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $9.1

  • Market Cap

    $368.24 Million

  • Price-Earnings Ratio

    -1.63

  • Total Outstanding Shares

    40.63 Million Shares

  • Total Employees

    748

  • Dividend

    No dividend

  • IPO Date

    May 27, 2004

  • SIC Description

    Surgical & Medical Instruments & Apparatus

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    14 plaza drive, Latham, NY, 12110

  • Homepage

    https://www.angiodynamics.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

December 1, 2023 to November 30, 2024
MetricValue
Exchange Gains/Losses$-266,000
Net Cash Flow From Financing Activities$-5.94 Million
Net Cash Flow$-6.81 Million
Net Cash Flow From Investing Activities$22.70 Million
Net Cash Flow From Operating Activities, Continuing$-23.30 Million
Net Cash Flow From Investing Activities, Continuing$22.70 Million

Income Statement

December 1, 2023 to November 30, 2024
MetricValue
Income Tax Expense/Benefit, Deferred$-13.51 Million
Basic Earnings Per Share$-5.57
Preferred Stock Dividends And Other Adjustments$0
Cost Of Revenue$135.49 Million
Operating Income/Loss$-238.54 Million
Other Operating Expenses$348.10 Million

Comprehensive Income

December 1, 2023 to November 30, 2024
MetricValue
Comprehensive Income/Loss$-223.76 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$171.86 Million
Comprehensive Income/Loss Attributable To Parent$-223.76 Million

Balance Sheet

December 1, 2023 to November 30, 2024
MetricValue
Noncurrent Assets$116.19 Million
Current Liabilities$88.59 Million
Other Non-current Assets$10.10 Million
Other Current Liabilities$40.71 Million
Intangible Assets$73.11 Million
Equity Attributable To Parent$186.77 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ANGO from trusted financial sources

    Related Companies

    Additional publicly traded companies similar to AngioDynamics (ANGO)
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.